Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion type Assertion NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_head.
- NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion wasGeneratedBy ECO_0000203 NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_provenance.
- NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion wasDerivedFrom befree-20140225 NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_provenance.
- NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion SIO_000772 9652749 NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_provenance.
- NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion evidence source_evidence_literature NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_provenance.
- NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_assertion description "[We found no consistent evidence of aberrant splicing or point mutations in breast cancer or Wilms' tumor suggesting that TSG101 is not a primary target of inactivation in human cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165053.RAzZXZEo0oIZdIR9vmZJe4IPWrbfr0dRkSH2KTagCytPs130_provenance.